Highest overallLowest published start
TMates
People who value predictable dose pricing and are already comfortable with a 12-month commitment.
63/100
Overall score
84/100
Transparency
- Published ongoing total
- From $158/mo with a 12-month plan
- Membership
- Evaluation included; no separate membership published
- Medication
- Semaglutide from $158/mo and tirzepatide from $167/mo on a 12-month plan
- Commitment
- 12-month plan for the published lowest price
- Medication model
- Compounded injection and oral options
- Clinical support
- Evaluation, medication, shipping, and clinician support included
- Independent reputation
3.2/51 company reviews ↗
- Community survey
- Not measured in the referenced survey
Before you enroll
- The lowest published price requires a 12-month plan
- Compounded medication is not FDA-approved
- Named provider and pharmacy details are limited before checkout
